Virginia Regulatory Town Hall
Agency
Virginia Department of Health
Board
State Board of Health
chapter
Regulations Governing Virginia Newborn Screening Services [12 VAC 5 ‑ 71]
Action is Exempt from Article 2 of the Administrative Process Act
Action:
Amend regulations to add Pompe disease and mucopolysaccharidosis type 1 (MPS 1)
Action 5111
 
General Information
Action Summary Adds Pompe disease and mucopolysaccharidosis type 1 (MPS 1) to the Virginia Newborn Screening System's core panel of heritable disorders and genetic diseases
Chapters Affected Only affects this chapter.
Executive Branch Review This Action is exempt from Article 2 of the Administrative Process Act. The normal executive branch review process is not required. As such, it can be submitted directly for publication and is effective upon publication.
Exempt Citation: Section 2.2-4006 A 4 a of the Code of Virginia
RIS Project Yes  [005461]
Is Federal action a driving factor in this regulatory change? If so, please provide a specific reference to the law, regulation or court case.
No
Associated Mandates Amend Newborn Screening Regulations
New Periodic Review This action will not be used to conduct a new periodic review.
 
Stages
Stages associated with this regulatory action.
Stage ID Stage Type Status
8367 Final Stage complete. This regulation became effective on 01/01/2019.
 
Contact Information
Name / Title: Michael Capps  / Sr. Policy Analyst
Address: James Madison Building
109 Governor Street
Richmond, VA 23219
Email Address: boardofhealth@vdh.virginia.gov
Phone: (804) 864-7190    FAX: (804)864-7022    TDD: ()-

This person is the primary contact for this agency.